Buscar resultados de ensayos clínicos
Ependymoma - 154 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma Condición:
Fecha: 2007-01-30 Intervenciones: |
Terminated |
Nombre del estudio: Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors Condición:
Fecha: 2005-05-03 Intervenciones: |
Completed |
Nombre del estudio: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Condición:
Fecha: 2002-02-14 Intervenciones: |
Terminated |
Nombre del estudio: Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases Condición:
|
Withdrawn |
Nombre del estudio: Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Condición:
|
Terminated |
Nombre del estudio: Antineoplaston Therapy in Treating Patients With Ependymoma Condición: Ependymoma Fecha: 1999-11-01 Intervenciones: Drug: Antineoplaston therapy (Atengenal + Astugenal) Patients with an ependymoma will receive Antineopla |
Terminated |
Nombre del estudio: Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma Condición: Ependymoma Fecha: 2010-03-16 Intervenciones: Drug: Carboplatin Patients will receive daily carboplatin as a radiation sensitizer prior to radiation e |
Recruiting |
Nombre del estudio: Everolimus for Children With Recurrent or Progressive Ependymoma Condición: Recurrent Childhood Ependymoma Fecha: 2014-05-29 Intervenciones: Drug: Everolimus The recommended dose of Everolimus is 4.5 mg/m2/dose, once daily for up to 2 years, unt |
Recruiting |
Nombre del estudio: A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma Condición: Ependymoma Fecha: 2014-04-25 Intervenciones:
|
Recruiting |
Nombre del estudio: Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod Condición: Ependymoma Fecha: 2013-02-12 Intervenciones:
|